The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Prince Bishop Denies U.S. Runners in Dubai
- Mubtaahij Easily Earns Kentucky Derby Spot
- Unbeaten Materiality Secures Florida Derby
- International Star Sweeps to LA Derby Score
- I'm a Chatterbox Notches Easy FG Oaks Victory
- Birdatthewire Tops Familiar Rivals in GP Oaks
- Dortmund Logs Final Work for SA Derby
- The Big Beast, 3YOs Prep for Wood Day Starts
- Champion Groupie Doll Delivers Premature Foal
- Call Me George Pulls New Orleans 'Cap Upset